Compare LCTX & SGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCTX | SGU |
|---|---|---|
| Founded | 1990 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.6M | 410.0M |
| IPO Year | 1996 | 1997 |
| Metric | LCTX | SGU |
|---|---|---|
| Price | $1.38 | $12.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 19.3K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $14,556,000.00 | ★ $1,784,418,000.00 |
| Revenue This Year | $109.40 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.70 |
| Revenue Growth | ★ 53.24 | 1.04 |
| 52 Week Low | $0.45 | $11.31 |
| 52 Week High | $2.09 | $13.53 |
| Indicator | LCTX | SGU |
|---|---|---|
| Relative Strength Index (RSI) | 34.91 | 50.44 |
| Support Level | $1.14 | $12.32 |
| Resistance Level | $1.80 | $12.99 |
| Average True Range (ATR) | 0.08 | 0.34 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 4.48 | 37.50 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.